$25M Dev Bonus is Qualifying Sanofi's insulin for Afrezza?

[lakers]

$25M dev bonus is for Qualifying Sanofi's insulin for Afrezza.

Jay Olson - Goldman Sachs

All right. Thanks for taking the questions. I have a few of them. I believe there is a $25 million milestone payment that should be coming due soon that's related to manufacturing. Can you comment on when we should expect that?

Hakan Edstrom - President and CEO

No, there is no manufacturing milestone payment that's coming due now. The only additional milestone payment that would be forthcoming would be in conjunction with some R&D activities. That would be any collaborative activity together with Sanofi.

Jay Olson - Goldman Sachs

Okay, and should we expect to see that this year?

Hakan Edstrom - President and CEO

I cannot give you a timing for that one. That's a decision by Sanofi, and they have that as part of their internal programming. So I could not give you a timing on that.

seekingalpha.com/article/3669586-mannkinds-mnkd-ceo-hakan-edstrom-on-q3-2015-results-earnings-call-transcript?part=single

[liane]

lakers,

You're stating your opinion as if it were fact. Please be more careful with your posts.

[lakers]

seekingalpha.com/article/3681646-amphastar-pharmaceuticals-amph-q3-2015-results-earnings-call-transcript?part=single

Our Insulin API business generated sales of $6 million which was the same amount as we sold in the third quarter of 2014.

The timing of certain insulin shipments is variable and depending on other couple of different factors.


Attachment Deleted